This framework achieves high diagnostic accuracy in dermatology by leveraging multimodal data while ensuring privacy and clarity.
Advances in generative and federated artificial intelligence enable privacy-aware diagnostic systems that integrate multimodal reasoning and explainability. This work introduces DermaGPT, a federated multimodal framework for dermatology decision support that emphasizes trustworthy use under heterogeneous, privacy-sensitive data. The system combines a PaLI-Gemma 2 vision-language backbone, fine-tuned with low-rank adaptation, with a retrieval-augmented large language model that generates clinically coherent and patient-friendly explanations. To improve robustness and calibration across sites, a meta-learned trust function (MLTF) dynamically re-weights client updates based on uncertainty, calibration, and domain-shift indicators. Evaluated on four institutional datasets and an external cohort of 4,452 biopsy-confirmed clinical and dermoscopic images, DermaGPT achieved 90.2% diagnostic accuracy across 11 lesion types and 93.3% accuracy in malignancy prediction, with well-calibrated outputs under federated training. Expert dermatologists rated its explanations as clear and clinically relevant; these ratings were obtained on class-level canonical exemplars rather than per-image reports. In our deployment threat model, images are processed locally by the vision module; when a third-party LLM is used, only text (a short diagnostic summary and the user question) is transmitted, which may still be considered sensitive health data. Taken together, these results indicate that a trust-aware, federated multimodal design can deliver interpretable, efficient, and privacy-aware dermatology decision support that is intended to augment rather than replace clinician judgment.
No takes yet. Share an insight, caveat, or question.
Hashjin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: